Inforlife Company Profile
✉ Email this page to a colleague
What is the competitive landscape for INFORLIFE
INFORLIFE has eleven approved drugs.
There are four US patents protecting INFORLIFE drugs.
Summary for Inforlife
| US Patents: | 4 |
| Tradenames: | 11 |
| Ingredients: | 10 |
| NDAs: | 11 |
| Patent Litigation for Inforlife: | See patent lawsuits for Inforlife |
Drugs and US Patents for Inforlife
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inforlife | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 215700-001 | Sep 15, 2022 | RX | Yes | Yes | 10,888,534 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Inforlife | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 215700-001 | Sep 15, 2022 | RX | Yes | Yes | RE49422 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Inforlife | CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER | ciprofloxacin | INJECTABLE;INJECTION | 078252-002 | Mar 18, 2008 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Inforlife | NOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE | norepinephrine bitartrate | SOLUTION;INTRAVENOUS | 215700-003 | Sep 15, 2022 | RX | Yes | Yes | RE49443 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Inforlife Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Spain | 2663817 | ⤷ Start Trial |
| Argentina | 101148 | ⤷ Start Trial |
| Lithuania | 3110399 | ⤷ Start Trial |
| Nicaragua | 201600118 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Inforlife Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0239710 | 96C0042 | Belgium | ⤷ Start Trial | PRODUCT NAME: CHLORHYDRATE DE ROPIVACAINE MONOHYDRATE; NAT. REGISTRATION NO/DATE: 212 IS 216 F 12 19960806; FIRST REGISTRATION: SE 12319 19950915 |
| 0275821 | 01C0035 | France | ⤷ Start Trial | PRODUCT NAME: ZOLEDRONIC ACID; NAT REG. NO/DATE: EU/1/01/176/001 20010320; FIRST REG.: LI IKS N 55 463 20001128 |
| 0206283 | SPC/GB97/085 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: LEVOFLOXACIN, OPTIONALLY IN THE FORM OF A HEMIHYDRATE; REGISTERED: UK 13402/0011 19970606; UK 13402/0012 19970606; UK 13402/0013 19970606 |
| 1429780 | 132013902137451 | Italy | ⤷ Start Trial | PRODUCT NAME: CIPROFLOXACINA E DESAMETASONE(CILODEX); AUTHORISATION NUMBER(S) AND DATE(S): 48976, 20120810;041182015/M, 20121106 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
